Private equity investment in healthcare hits record $191 billion as firms target AI and physician practices

Private equity capital surged to historic levels in healthcare during 2025, with global PE firms deploying a record $191 billion in deal value across the sector. This figure eclipsed the previous record set in 2021, underscoring sustained institutional appetite for healthcare acquisitions despite broader macroeconomic headwinds affecting other sectors. The activity level—reflected in 445 completed buyouts, the second-highest annual count on record—demonstrates PE's continued pivotal role in reshaping healthcare delivery and operations as traditional public funding sources face constraints.

The recovery in exit valuations provides particular evidence of market health. After a compressed 2024 when exits totaled just $54 billion, portfolio companies generated $156 billion in exit value during 2025, signaling that PE sponsors successfully created value and found buyer interest in healthcare assets. This rebound follows cyclical patterns typical in PE markets when interest rate environments stabilize and strategic buyer appetite increases.

Healthcare technology and artificial intelligence represented the most aggressive capital concentration within the broader $191 billion deployment. Healthcare IT deal value doubled to roughly $32 billion in 2025, with PE-specific investments reaching $14.6 billion—a dramatic 595% increase from $2 billion in 2024. This concentration reflects market recognition that AI-driven operational efficiencies (payment processing, claims submission, revenue cycle management) and clinical applications represent material competitive advantages. Digital health fundraising reinforced this trend, with companies raising $7.4 billion in the first half of 2026 alone, compared to $6.4 billion in the equivalent 2025 period, indicating that capital velocity in healthcare technology remains accelerating.

PE firms are increasingly evaluating healthcare targets through an explicit "AI readiness" lens, assessing portfolio companies' capacity to integrate and scale artificial intelligence capabilities. Beyond administrative workflows, clinical AI applications present opportunities and regulatory complexities that will likely dominate portfolio company strategy over the coming 18-24 months. Alongside healthcare IT, physician practices and post-acute care segments are also commanding significant PE attention, reflecting a broader thesis that fragmented, undermanaged care delivery networks represent consolidation opportunities with margin expansion potential.